NCT05830630 Perineural Methylene Blue Infusion in Lower Limb Amputation Surgery
| NCT ID | NCT05830630 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Perineural |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2023-05-01 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective randomized controlled study will be conducted to evaluate the analgesic effect of continuous perineural infusion of methylene blue with bupivacaine on acute postoperative pain and to evaluate its preventive role against chronic phantom pain in patients undergoing lower limb amputation surgery
Eligibility Criteria
Inclusion Criteria: * Patients of both genders, suffering from vascular insufficiency of one or both lower limbs and scheduled for above or below knee amputation under general anesthesia. Exclusion Criteria: * Patients with a history of allergy to local anesthetics. * Patients with allergy to methylene blue. * Anticoagulant use or coagulopathy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05830630 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Perineural. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05830630 currently recruiting?
Yes, NCT05830630 is actively recruiting participants. Contact the research team at osamarehab@med.tanta.edu.eg for enrollment information.
Where is the NCT05830630 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT05830630 clinical trial?
NCT05830630 is sponsored by Tanta University. The trial plans to enroll 72 participants.